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Abstract
The glomerular filtration barrier (GFB) plays a critical role in ensuing protein free
urine. The integrity of the GFB is compromised during hypoxia that prevails during
extreme physiological conditions. However, the mechanism by which glomerular
permselectivity is compromised during hypoxia remains enigmatic. Rats exposed to
hypoxia showed a decreased glomerular filtration rate, podocyte foot‐processes
effacement, and proteinuria. Accumulation of hypoxia‐inducible factor‐1α (HIF1α) in
podocytes resulted in elevated expression of zinc finger E‐box binding homeobox 2
(ZEB2) and decreased expression of E‐ and P‐cadherin. We also demonstrated that
HIF1α binds to hypoxia response element localized in the ZEB2 promoter.
Furthermore, HIF1α also induced the expression of ZEB2‐natural antisense
transcript, which is known to increase the efficiency of ZEB2 translation. Ectopic
expression of ZEB2 induced loss of E‐ and P‐cadherin and is associated with enhanced
motility of podocytes during hypoxic conditions. ZEB2 knockdown abrogated
hypoxia‐induced decrease in podocyte permselectivity. This study suggests that
hypoxia leads to activation of HIF1α–ZEB2 axis, resulting in podocyte injury and poor
renal outcome.
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1 | INTRODUCTION
Oxygen is a vital element and supports most of the metabolic events
in higher organisms. The continuous supply of adequate levels of
oxygen is crucial for normal functioning of the human body.
However, human physiology is challenged with extreme environ-
mental conditions resulting in hypoxia, a state of deficiency of oxygen
in the blood and tissues. Hypoxia affects the homeostasis and
functioning of various organs including kidneys. Kidneys possess low‐
resistance microvasculature that is exposed to both high volume and
continuous perfusion. The kidneys have a high oxygen demand, so as
to facilitate energy dependent basic renal functions such as active
salt absorption (Hansell, Welch, Blantz, & Palm, 2013). The
constraints of low oxygen supply, dictated by both renal architecture
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and high oxygen demand, coalesce to make the kidney vulnerable to
physiologic, environmental, and pathological stresses that cause
hypoxia. The limitation in renal tissue oxygen supply during chronic
hypoxia exposes the kidneys to hypoxia‐induced adaptations and has
long been recognized as an important factor in the pathogenesis of
acute renal injury (Eckardt et al., 2005; Goldfarb‐Rumyantzev &
Alper, 2014; Kushida et al., 2016; Munshi, Hsu, & Himmelfarb, 2011;
S. Tanaka, Tanaka, & Nangaku, 2016).
The vertebrate kidneys play an essential role in the maintenance
of homeostasis via its role in the filtration of plasma and the
regulation of water, electrolyte, and acid–base balance. The function
of the kidneys is to ensure almost protein free ultrafiltrated urine.
The presence of proteins in the urine (proteinuria) is an indication of
renal injury, particularly aberrations in the glomerular filtration
barrier (GFB). The crucial components of GFB include the glomerular
capillary endothelium, basement membrane, and glomerular podo-
cytes (Anil Kumar, Welsh, Saleem, & Menon, 2014). Albuminuria is an
index of adverse renal outcome that can be assessed by measuring
albumin levels in urine. Microalbuminuria describes levels of urine
albumin ranging from 30 to 300mg/24 hr, and macroalbuminuria
describes a urinary albumin excretion of ≥300mg/24 hr. The
condition of macroalbuminuria often progresses to overt proteinuria
and even to end‐stage renal disease (ESRD) and is driven by an array
of interlinked risk factors such as anemia, atherosclerosis, hypergly-
cemia, hypertension, repeated episodes of acute kidney injury,
smoking, stroke, and sleep apnea, so forth. It has been well
established that all these factors subject the kidneys to hypoxia
(Adeseun & Rosas, 2010; Fu, Colgan, & Shelley, 2016; Tao et al.,
2016). It was proposed that chronic hypoxia is the common pathway
that leads to the ESRD (Fine, Bandyopadhay, & Norman, 2000) and
progression of chronic renal disease (Eckardt et al., 2005; Fine et al.,
2000; Fu et al., 2016; Munshi et al., 2011; Palm & Nordquist, 2011;
T. Tanaka, Miyata, Inagi, Fujita, & Nangaku, 2004).
Population‐based studies demonstrated that approximately
10−20% of adults have proteinuria in their lifetime (Chadban et al.,
2003; Coresh, Astor, Greene, Eknoyan, & Levey, 2003). The incidence
of ESRD has already reached epidemic proportions in many
countries. Furthermore, the rates of ESRD among the elderly are
disproportionally high. Considering the magnitude of the population
with proteinuria and association of proteinuria with the clinical
conditions wherein hypoxia prevails, it is important to understand
the underlying mechanism of renal dysfunction to develop preventive
and therapeutic strategies. Our understanding of the physiological
and cellular events that transduce hypoxia‐mediated events to
adverse glomerular function is very limiting. In the current study,
we investigated the mechanism of renal dysfunction following
chronic hypoxia in rats and found that hypoxia results in elevated
expression of hypoxia‐inducible factor‐1α (HIF1α) in the glomerular
region. Elevated HIF1α in turn induced zinc finger E‐box binding
homeobox 2 (ZEB2) expression, both by directly interacting with the
ZEB2 promoter and by increasing expression of a ZEB2‐ natural
antisense transcript (ZEB2‐NAT). Ectopic expression of ZEB2
induced loss of E‐ and P‐cadherin and was associated with enhanced
migration of cells. Finally, hypoxia ablated the podocyte permselec-
tivity, whereas ZEB2 knockdown abrogated this effect. Elevated
expression of ZEB2 is implicated in podocyte epithelial–mesenchy-
mal transition (EMT) and foot‐process effacement during acute
hypoxia. We conclude that hyperactivity of the HIF1α–ZEB2 axis is
one of the mechanisms by which acute systemic hypoxia provokes
poor renal outcome.
2 | MATERIALS AND METHODS
2.1 | Reagents and plasmids
Antibodies for P‐cadherin (#sc‐1501), WT1 (#sc‐192), nephrin
(#sc‐376522), ZO‐1 (#sc‐33725) were obtained from Santa Cruz
Biotechnology (Dallas, TX); ZEB2 (#PA5–20980) was purchased from
Thermo Fisher Scientific (Waltham, MA). Actin (#4970), CD2AP
(#2135), HIF1α (#14179, #79233), N‐cadherin (#4061), MMP2
(#4022), E‐cadherin (#3195), MMP9 (#3852), MMP2 (#4022), VEGF
(#9943), tissue transglutaminase (TG2; #73612), Vimentin (#5741),
β‐catenin (#8480), Histone3 (#4499), FSP1 (#13018) were procured
from Cell Signaling Technologies (Danvers, MA). Podocin antibody is a
gift from Rakesh Verma (University of Michigan, Ann Arbor, MI).
Secondary antibodies were purchased from The Jackson Laboratory
(Bar Harbor, ME). All primers used in this study procured from
Integrated DNA Technologies (Coralville, IA). RNA isolation kit was
purchased from Qiagen (Hilden, Germany). The high capacity cDNA
reverse transcription kit, SYBR Green Master Mix, and enhanced
chemiluminescence (ECL) western blot analysis reagents were obtained
from Bio‐Rad Laboratories (Hercules, CA). Fetal bovine serum, RPMI‐
1640, and TRIzol reagent were procured from Life Technologies
(Carlsbad, CA). Dual‐Luciferase Assay System was procured from
Promega (Madison, WI). E‐cadherin‐luciferase reporter construct (Hajra,
Chen, & Fearon, 2002) was a gift from Dr. Eric Fearon (University of
Michigan). Hypoxia response elements (HRE1 & 2) in the ZEB2
promoter and ZEB2 binding sites in E‐cadherin promoter (E2‐box 1
and E2‐box 3) were mutated using the Quick‐Change Site‐Directed
Mutagenesis Kit from Stratagene (La Jolla, CA). ZEB2 and ZEB2‐NAT
promoter constructs (Beltran et al., 2008) were a gift from Dr. Antonio
Garciá de Herreros (IMIM, Universitat Pompeu Fabra, Barcelona, Spain).
ZEB2 expression construct (Christoffersen, Silahtaroglu, Orom, Kauppi-
nen, & Lund, 2007) was a gift from Dr. Anders Lund (University of
Copenhagen, Copenhagen, Denmark). All other chemicals used were of
analytical grade and obtained from Sigma-Aldrich (St. Louis, MO).
2.2 | Hypoxia treatments and surgical procedures
Wistar rats weighing 190 ± 10 g, provided by the National Center for
Laboratory Animal Sciences (Hyderabad, India), were maintained at
22 ± 1°C and relative humidity of 50 ± 5% under a 12‐hr light–12‐hr
dark cycle with food and water ad libitum. Rats were allowed to
acclimatize to the animal facility for 1 week. Rats were randomly
divided into normoxia and hypoxia cohorts (n = 10). Rats in the
normoxia group were maintained in a chamber with a fraction of
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inspired oxygen (FIO) of ~0.21 for 2 weeks. Hypoxia exposure to rats
was performed as described earlier (Fan et al., 2016). Briefly, rats
were exposed to FIO of 0.1 for 23 hr (hypoxia) and FIO of 0.21
(normoxia) for 1 hr each day and were maintained for 2 weeks
(Figure 1a). Rats from both groups were transcardially perfused
under anesthesia with saline. Organs were harvested and frozen
immediately for further processing or processed for histopathology.
The Institutional Animal Ethics Committee of the University of
Hyderabad approved animal care and experimental protocols.
2.3 | Estimation of glomerular filtration rate (GFR)
and urine parameters
GFR was estimated in rats (n = 6) following 2 weeks of exposure to
hypoxia using a commercially available kit (#FIT‐0415; BioPAL,
Worcester, MA). Briefly, a single intraperitoneal injection of inulin
(25mg/kg) was given followed by saphenous bleeds at 5, 10, 30, 60,
and 90min. Plasma was collected, and inulin concentration was
estimated using functional immunoassay technology. Plasma clearance
of inulin was determined by nonlinear regression using a one‐phase
exponential decay formula, and GFR was calculated from inulin
clearance as described earlier (O’Brien et al., 2013). Alternatively, spot
urine was collected from control and experimental rats and
centrifuged at 2,000g for 5min. Urinary albumin (#COD11573) and
creatinine (#COD11502) levels were estimated using commercially
available assay kits (Biosystems, Barcelona, Spain).
2.4 | Histological examination and transmission
electron microscopy (TEM)
Renal cortical samples were fixed in 4% neutral buffered formalin,
embedded in paraffin, sectioned (4 μm), stained with the periodic acid–
Schiff (PAS) stain and images were acquired using Olympus 5000
microscope (Olympus Corporation, Waltham, MA) with ×40 magnifica-
tion. The glomerular tuft area was measured as described earlier
(Stojanovic et al., 2012). The extent of glomerulosclerosis index was
determined in PAS‐stained sections with the scoring system as
described earlier (Babelova et al., 2013; Hartner et al., 2001). Briefly,
0: normal glomerulus; 1: mesangial expansion or sclerosis involving up to
25% of the glomerular tuft; 2: sclerosis of 25–50%; 3: sclerosis of 50–75%
F IGURE 1 Chronic hypoxia alters renal function. (a) Outline of animal experiment. Control rats were maintained at normoxia (24 hr × 2 weeks),
and experimental rats were exposed to hypoxia (23 hr × 2 weeks). After 2 weeks, we assessed renal function tests and histological parameters.
(b) Measurement of GFR in rats exposed to hypoxia (n = 6, *p < 0.01). (c) Estimation of albumin and creatinine levels in rats exposed to hypoxia. The
ratio of albumin–creatinine is shown in the form of a bar diagram in each condition (n = 6, *p < 0.01). (d) Urine protein analysis in rats exposed to
hypoxia. Urine samples were subjected to SDS‐PAGE, and band intensities were visualized by silver staining as described in Section 2. M, molecular
weight marker (#1610374; Bio‐Rad); C, urine from control rat; H, urine from the rat exposed to hypoxia; and BSA was used as a standard. (e) PAS
staining of glomerular regions of rats exposed to hypoxia. (f) Glomerulosclerosis index was assessed as described in Section 2 and (g) measurement
of glomerular tuft area in rats exposed to hypoxia. Error bars indicate mean ± SE; n = 6; *p ≤ 0.05. BSA: bovine serum albumin; GFR: glomerular
filtration rate; PAS: periodic acid–Schiff; SDS‐PAGE: sodium dodecyl sulfate–polyacrylamide gel electrophoresis
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and/or segmental extracapillary fibrosis or proliferation; and 4: global
sclerosis > 75%, global extracapillary fibrosis or complete collapse of the
glomerular tuft. For TEM analysis, renal cortex from control and
experimental rats were fixed in 2.5% glutaraldehyde for 24 hr. After
washing with 1× phosphate‐buffered saline (PBS) for four times, cortical
tissues were fixed in 1% osmium tetroxide for 2 hr and ultrathin
sections (60 nm) were cut and mounted on 200‐mesh copper grids.
These copper grids were stained on a Leica EM AC20 strainer (Leica
Microsystems Inc, Buffalo Grove, IL) with 3% aqueous uranyl acetate
and 3% lead citrate solution. Images were acquired on a JEM‐1400 TEM
(Jeol, Peabody, MA) using a Gatan ultrascan CCD camera (Gatan Inc,
Pleasanton, CA) at 2K × 2K resolution and 120 kV.
2.5 | Isolation of kidney glomeruli
The glomeruli from the kidneys of control and rats exposed to
hypoxia were isolated by a series of stainless sieves (Krtil, Platenik,
Kazderova, Tesar, & Zima, 2007). Briefly, under aseptic conditions,
decapsulated rat kidney slices were placed on a sieve with a size of
200 μm and gently grounded with a sterile syringe knob and washed
with Hank’s solution. The filtered kidney lysate was then allowed to
pass through decreasing pore size sieve of 150 μm and as a final step;
the glomeruli were then collected as a suspension on a 75 μm sieve.
After incubation for 10min, the suspensions were centrifuged for
5min at 1000 rpm, then the supernatant was discarded, the purified
glomerular precipitations were used for immunoblotting and gene
expression studies.
2.6 | Silver staining of urine samples
Urine samples are collected from control and rats exposed to hypoxia
and protein concentrations were estimated using the Bradford assay.
Equal amounts of protein were subjected to sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS‐PAGE), following which gel was
placed in fixing solution (50%methyl alcohol and 10% glacial acetic acid)
for 1 hr at room temperature. Then, the gel was washed with 50%
ethanol and sensitized with sodium thiosulfate for 1min. After washing
with distilled water, the gel was incubated with 0.2% silver nitrate
solution containing 0.037ml formaldehyde for 30min. The gel was
briefly washed and then developed in 6% sodium carbonate, containing
0.037ml formaldehyde solution until protein bands were sufficiently
dark. The reaction was terminated by placing the gel in 1% glacial acetic
acid solution and visualized by Bio‐Rad image analyzer.
2.7 | Culturing of podocytes and HEK293T cells
Human podocytes were obtained from the University of Bristol
(Bristol, UK) and were cultured as described earlier (Ni, Saleem, &
Mathieson, 2012). Briefly, podocytes were propagated at 33°C
(permissive conditions) and 5% CO2 in RPMI‐1640 medium containing
10% fetal bovine serum (FBS), 100 units/ml penicillin, 100mg/ml
streptomycin, and 1% insulin–transferrin–selenium solution. At ~60%
confluence, these cells were transferred to 37°C (nonpermissive
condition) tissue culture incubator with 5% CO2 for 6 days to silence
the temperature‐sensitive tsA58T antigen to allow podocyte differ-
entiation. Differentiation of podocytes was achieved by a growth
arrest and the upregulation of cyclin‐dependent kinase inhibitors. Cells
used for experimentation were from passages 10 to 16. HEK293T cells
were cultured in Dulbecco’s modified Eagle’s medium supplemented
with 10% FBS, 100 units/ml penicillin, 100mg/ml streptomycin
and incubated at 37°C and 5% CO2. Differentiated podocytes and
HEK293T cells were exposed to hypoxia using a modular gas chamber
inside CO2 incubator where along with carbon dioxide; nitrogen gas
was supplied to reduce the oxygen levels to 1% for 24 hr.
2.8 | Immunoblotting
Glomerular lysates from rat kidney cortex, human podocytes, and
HEK293T cells were processed for immunoblotting. An equal
amount of protein from control and experimental samples was
electrophoresed through 10% SDS‐PAGE. After electrophoresis, the
proteins were transferred to nitrocellulose membrane by electro-
blotting. The nitrocellulose membrane was then blocked in 5%
nonfat milk for 1 hr, and subsequently probed with the indicated
primary (1:1,000 dilution) and secondary antibodies (1:10,000
dilution). Blots were developed using the ECL western blot analysis
substrate.
2.9 | Quantitative real‐time polymerase chain
reaction (qRT‐PCR) analysis
Total RNA from rat glomeruli, human podocytes, and HEK293T
cells was extracted using TRIzol reagent and isolated using an
RNA isolation kit. RT‐PCR was performed using iQ SYBR Green
Supermix (Bio-Rad Laboratories, Hercules, CA). Messenger RNA
(mRNA) expression levels were normalized using the expression
of β‐actin, and data were analyzed using the comparative thresh-
old cycle method.
2.10 | Immunofluorescence analysis
Cells cultured on coverslips were fixed with 4% paraformaldehyde,
permeabilized with 0.1% Triton X‐100 and blocked with 3% bovine
serum albumin (BSA) in 1× PBS. Cells were incubated with primary
antibodies for HIF1α (1:100) and ZEB2 (1:100). HIF1α and ZEB2
were visualized using Cy5 horse anti‐mouse IgG (1:200) and
DyLight594 anti‐rabbit IgG (1:200), respectively (Vector Labora-
tories, Burlingame, CA). ProLong gold antifade with 4′,6‐diamidi-
no‐2‐phenylindole is used to mount the slides (Thermo Fisher
Scientific, Waltham, MA). Images were acquired using a confocal
microscope (ZEISS, Thornwood, NY) at ×63 magnification. Simi-
larly, expression of HIF1α and ZEB2 in glomerular sections of
experimental rats were analyzed using a trinocular microscope
(Leica, Buffalo Grove, IL).
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2.11 | Cell migration assay
Both differentiated human podocytes and HEK293T cells were
seeded in six‐well plates and grown under normal growth conditions
to reach 95% confluence. When the cells are confluent, media was
aspirated, and a scratch was made in a sweeping motion using a 10‐µl
sterile pipette tip. Cells were washed with prewarmed media to
remove debris from damaged cells. Images of cells were taken
following exposure to hypoxia at regular time points to monitor the
rate of cell migration into the wound field. The area covered by cells
is quantified using Image J software (NIH, Bethesda, MD) and
represented as the percentage of area coverage (cell area/region of
interest area ×100).
2.12 | Short hairpin RNA (shRNA)‐mediated ZEB2
knockdown in podocytes
ZEB2 expression in human podocytes was knockdown as described
earlier (Kumar et al., 2010). Lentiviral particles expressing unique
ZEB2 shRNA sequences and scrambled shRNA were purchased from
Sigma‐Aldrich (St. Louis, MO). Podocytes were cultured in a six‐well
plate under permissive growth conditions for 16 hr. The cells were
then pretreated with 6 µg/ml polybrene and infected with indicated
lentiviral particles. Next day the medium was replaced with fresh
medium, and shRNA‐infected cells were selected with 1 µg/ml
puromycin. Puromycin‐resistant cells were induced to differentiate
under nonpermissive conditions, and ZEB2 expression was verified in
the differentiated cells using qRT‐PCR and immunoblotting.
2.13 | Albumin influx assay
Podocyte permselectivity was assessed using paracellular albumin influx
assay as described previously (Kumar et al., 2010). Corning Transwell
Collagen‐Coated 3.0 μm pore polytetrafluoroethylene (PTFE) mem-
brane inserts (#CLS3494; Sigma-Aldrich, St. Louis, MO) were used in
this study. Podocytes were seeded on the transwell insert and placed in
a 12‐well tissue culture plate, during which transwell insert serves as
upper chamber and cell culture well serve as a bottom chamber
(Figure 8a). Podocytes were cultured under nonpermissive conditions
for 6 days as detailed above in the methods section. These
differentiated cells were exposed to hypoxia for 24 hr. Subsequently,
the cells were washed twice with 1× PBS containing CaCl2 andMgCl2 to
preserve cadherin junctions. Two milliliter of RPMI‐1640 medium with
40mg/ml BSA was placed in the bottom chamber, and 300 µl of RPMI‐
1640 medium (without BSA) was placed in the upper chamber. The cells
were incubated at 37°C, aliquots of medium were collected from the
upper chamber at regular intervals, and albumin concentration was
measured from these aliquots.
2.14 | Transient transfection and luciferase assay
HEK293T cells were transfected with a promoter–reporter construct
(ZEB2/E‐cadherin) and internal control expressing the Renilla
luciferase, pRL‐TK (Promega). HEK293T cells were transfected using
Xfect polymer (DSS Takara Bio, New Delhi, India) as per manufac-
turer’s instructions. After 48 hr of transfection, cells were washed
twice with 1× PBS and harvested in 100 μl of passive lysis buffer.
After a brief freeze‐thaw cycle, the insoluble debris was removed by
centrifugation at 12,000g (4°C for 5min), and 20 μl of supernatant
was used for luciferase assay. The activity of the cotransfected R.
luciferase reporter plasmid was used to normalize transfection
efficiency.
2.15 | Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed as described previously (Mungamuri,
Wang, Manfredi, Gu, & Aaronson, 2015). HEK293T (2.5 × 106) cells
either naïve or exposed to hypoxia were taken for ChIP assay. Cross‐
linked chromatin from HEK293T cells was sonicated using S220
focused‐ultrasonicator (Covaris Inc, Woburn, MA). The whole cell
extract was precleared using 60 μl of Protein A/G PLUS‐agarose
beads (Thermo Fisher Scientific, Waltham, MA) and incubated
overnight with anti‐HIF1α and control IgG antibodies. One micro-
gram of anti‐HIF1α antibody was used for 100 μg of total cell lysate.
Protein G agarose beads (Millipore, Saint Charles, MO) preblocked
with salmon sperm DNA (60 μl) was used for each immunoprecipita-
tion. Ten percent of chromatin from each sample was removed
before immunoprecipitation and used as input for PCR amplification.
Both immunoprecipitated and input DNA were purified with PCR‐
purification kit (Qiagen, Valencia, CA). qRT‐PCR was performed on
this DNA to identify the amount of target sequence. HRE region of
the VEGFA promoter was used as a positive control, while the
primers that do not amplify the HRE region of the ZEB2 promoter
was used as a negative control.
2.16 | Statistical analysis
SPSS software was used to apply Mann–Whitney and Kruskal–Wallis
nonparametric tests to analyze statistical differences between the
distributions of two or multiple independent samples, respectively.
p ≤ 0.05 were considered as statistically significant.
3 | RESULTS
3.1 | Chronic hypoxia alters glomerular function
in vivo
To assess the impact of chronic hypoxia on renal function, we estimated
GFR in vivo (Figure 1b). Rats exposed to hypoxia displayed reduced GFR
(~29%) compared with control rats (2.42 vs. 3.45ml−1·min−1·kg−1 body
weight). To confirm the adverse effect of hypoxia on renal function, we
also assessed urinary albumin to creatinine ratio. Rats subjected to
hypoxia showed ~9‐fold increase in albumin excretion compared with
control rats (Figure 1c). Furthermore, urinary fractions collected from
rats exposed to hypoxia had a significant amount of protein as assessed
by SDS‐PAGE and visualized by silver staining (Figure 1d). We measured
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the extent of glomerulosclerosis in PAS‐stained glomeruli and
found that increased Bowman’s space, mild and diffuse glomerulo-
sclerosis (Figure 1e,f) and reduced glomerular tuft area (Figure 1g) in
rats exposed to hypoxia. Average glomerular tuft area in rats exposed to
hypoxia was 1.8 μm2 compared with 2.25 μm2 in control rats. All these
data suggested altered glomerular architecture and increased glomer-
ular permeability as evidenced by proteinuria in rats exposed to hypoxia.
3.2 | Chronic hypoxia‐induced podocyte injury in vivo
To understand the causative factors for proteinuria in rats exposed to
hypoxia, we next investigated whether there are any differences in
podocyte count and podocyte structure, using immunochemistry and
TEM techniques, respectively. We stained glomerular sections for WT1,
a putative marker for podocytes, to study the effect of hypoxia on
quantification of podocytes (Figure 2a). We noticed ~39% decrease in
podocytes number in experimental rats. When compare with podocyte
count of 23 ± 4/glomeruli in control rats, rats exposed to hypoxia had a
count of 14 ± 5 (Figure 2b). To ascertain the podocyte morphology, we
performed TEM analysis and observed foot‐processes effacement and
disruption of slit‐diaphragm from rats exposed to hypoxia (Figure 2c).
TEM images also revealed that there are no noticeable changes in
glomerular basement membrane and endothelium between control and
experimental rats (Figure 2c). All these data suggest podocyte injury in
rats exposed to hypoxia.
3.3 | Chronic hypoxia‐induced glomerular ZEB2
expression
Since, we observed significant morphological and functional changes in
the glomerular region, particularly in podocytes of rats exposed to
hypoxia, we would like to understand the molecular basis for the
observed pathological changes. HIF1α is a major transcription factor that
regulates the adaptive response to hypoxia. Earlier studies suggest that
activation of HIF1α is associated with progressive glomerulonephritis,
EMT, fibrosis, and renal failure (Fine & Norman, 2008). Considering the
significance of HIF1α under hypoxic conditions, we investigated HIF1α
expression in the glomerular region of rats exposed to chronic hypoxia.
As expected, we observed elevated expression of HIF1α in the glomerular
region of rats exposed to hypoxia (Figure 3a,b). Further, induction of
HIF1α is correlated with the upregulation of its downstream targets
including TG2, VEGFA, MMP2, and MMP9 and decreased expression of
podocyte‐specific proteins nephrin and podocin (Figure 3a,b). In addition
to these canonical HIF1α targets, we have also analyzed the expression of
ZEB2 in the glomerular region of the kidney, since ZEB2 gets upregulated
during podocyte injury and elevated ZEB2 expression is associated with
podocyte depletion (Chitra et al., 2015; Kumar et al., 2010). Interestingly,
we observed an elevated ZEB2 expression in glomerular extracts from
rats subjected to hypoxia, as measured at both protein (Figure 3a) and
mRNA (Figure 3b) levels. Immunofluorescence data confirms an elevated
expression of both HIF1α and ZEB2 in glomerular regions exposed to
hypoxia (Figure 3c). The data suggest that elevated expression of
glomerular HIF1α during hypoxia is associated with increased ZEB2
expression in proteinuric rats.
3.4 | Expression of ZEB2 and ZEB2‐NAT is
associated with EMT of human podocytes
ZEB2, which was increased in glomerular extracts of hypoxic rats, is
chosen for further analysis owing to its established role in EMT of
glomerular podocytes and altering podocyte permeability (Kumar
et al., 2010; Wiles, Bell, Thomas, Beckerle, & Lessnick, 2013). ZEB2 is
also involved in the development of the kidneys (Rasouly et al., 2016).
ZEB2 genomic locus also expresses ZEB2‐NAT in antisense manner
and is known to bind complementary region on ZEB2 mRNA and mask
the factors that would otherwise induce splicing (Beltran et al., 2008;
Wight & Werner, 2013). Thus, binding of ZEB2‐NAT to ZEB2 mRNA
prevents its splicing and augments ZEB2 mRNA translation (Kumar
et al., 2010). We found elevated expression of ZEB2‐NAT in addition
to ZEB2 mRNA in glomerular extracts of rats exposed to hypoxia
(Figure 4a), indicating dual regulation of ZEB2 mRNA under hypoxic
conditions; both at transcriptional (pre‐mRNA) and translational (post‐
mRNA) levels. Upon confirming the elevated expression of ZEB2 in
hypoxic rats, we assessed the expression of ZEB2 target genes and
EMT markers: E‐cadherin, a predominant epithelial marker; P‐cadherin
and ZO‐1, constituents of cell–cell junctions; N‐cadherin, vimentin, and
β‐catenin are mesenchymal markers. ZO-1, E-, and P‐cadherin
were downregulated, whereas N‐cadherin, vimentin, and β‐catenin
were upregulated in rat glomerular extracts in response to hypoxia
(Figure 4a,b). To validate the observations found in rats also holds true
in humans, we analyzed the expression of the same set of genes in
Nakagawa chronic kidney disease (CKD) data set available at
Nephroseq (https://nephroseq.org). This analysis revealed coexpres-
sion of HIF1α, ZEB2, β‐catenin in CKD data set (Figure 4c). It should be
noted that elevated expression of HIF1α is also associated with loss of
nephrin and podocin in CKD patients (Figure 4c). Thus, human renal
genome‐wide gene expression analysis also suggests a direct associa-
tion of elevated HIF1α levels with loss of podocyte‐specific gene
expression.
3.5 | Hypoxia induces HIF1α and ZEB2 expression
in podocytes in vitro
Glomerular podocytes are instrumental to ensure glomerular perms-
electivity (Anil Kumar et al., 2014). It was reported that podocytes
undergo EMT and such a glomerular injury with reduced podocyte
count was associated with proteinuria (Chitra et al., 2015; Nishad,
Nakuluri, Motrapu, & Pasupulati, 2017). To investigate whether the
observed proteinuria and decreased podocyte count in rats exposed
to hypoxia were owing to podocyte injury, we then investigated the
effect of hypoxia on human immortalized podocytes. As anticipated,
upon exposure to hypoxia, we noticed the accumulation of HIF1α in
podocytes (Figure 5a,b). In addition, we also observed elevated
expression of ZEB2 and N‐cadherin along with decreased expression
of E‐ and P‐cadherins (Figure 5a,b). We observed induction of
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ZEB2‐NAT in podocytes exposed to hypoxia (Figure 5b), similar to
the observations made in rat glomerular extracts. Next, we
investigated if there is any colocalization of HIF1α and ZEB2 in the
podocytes upon exposure to hypoxia (Figure 5c). In podocytes
cultured under normoxia, we observed very low levels of HIF1α. In
cells exposed to hypoxia HIF1α levels were elevated and predomi-
nantly found in the nucleus (Figure 5c). ZEB2 was also increased in
podocytes during hypoxic conditions (Figure 5c). Together, these
data obtained from podocytes (Figure 5c) and glomerular sections
(Figure 3c) suggest that both HIF1α and ZEB2 are localized to
glomerular podocytes during hypoxic conditions. Elevated expression
of ZEB2 in podocytes was associated with cadherin switch as
evidenced by attenuation of epithelial cadherins (E‐ and P‐cadherins)
and acquisition of mesenchymal cadherin (N‐cadherin; Figure 5a,b).
To ascertain the elevated expression of ZEB2 during hypoxia ensures
cadherin switch, we assessed cadherin expression in HEK293T cells
that ectopically express ZEB2 (Figure 5d). Ectopic expression of
ZEB2 resulted in the loss of E- and P-cadherins and increase in
N‐cadherin (Figure 5d). Cadherin switch that is associated with EMT
imparts enhanced migratory ability to cells (Wheelock, Shintani,
Maeda, Fukumoto, & Johnson, 2008). Therefore, we next assessed
the migratory properties of cells naïve to hypoxia or exposed to
hypoxia. Both, podocytes and HEK293T cells exposed to hypoxia
showed enhanced migratory properties as assessed by wound healing
F IGURE 2 Hypoxia induces podocyte injury. (a) WT1 staining of glomerulus from rats exposed to hypoxia. (b) Quantification of podocyte
number in these rats. Error bars indicate mean ± SE; n = 6; *p ≤ 0.05. (c) TEM images of podocytes from rats exposed to hypoxia. These are a
representative image out of 12 sections from each condition. Podocyte foot‐processes effacement and disruption of slit‐diaphragm can be
noticed from rats exposed to hypoxia. *Significant alterations in the morphology of podocyte foot-processes occurred in rats exposed to
hypoxia. DAPI: 4′,6‐diamidino‐2‐phenylindole; TEM: transmission electron microscopy
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assay (Figure 6a–c), a typical feature of cells that had undergone a
phenotypic switch from epithelial to mesenchymal state. To verify,
whether the enhanced migratory properties of these cells are indeed
due to elevated ZEB2 expression, we assessed migratory properties
of HEK293T cells that ectopically express ZEB2. Cells overexpressing
ZEB2 (Figure 6d) showed enhanced migratory properties upon
exposure to hypoxia (Figure 6e). Taken together these data suggest
the existence of a strong positive correlation of HIF1α and ZEB2
expression in the podocytes during hypoxia and induction of ZEB2
ensures podocytes acquire mesenchymal phenotype.
3.6 | HIF1α increases ZEB2 and ZEB2‐NAT
promoter activity
To investigate the effect of HIF1α on ZEB2 promoter activity, we
transiently transfected HEK293T cells with ZEB2 promoter–
luciferase construct and measured luciferase activity in the cell
lysates with and without hypoxia treatment. We observed an
increase in ZEB2 promoter activity in cells exposed to hypoxia
(Figure 7a). Similarly, ZEB2‐NAT promoter activity was also
increased with hypoxia (Figure 7a). To verify the specificity of
the effect of HIF1α on ZEB2 promoter activity, we tested the
effect of hypoxia on the promoter of an unrelated gene, growth
hormone receptor (GHR). Hypoxia had no effect on GHR promoter
activity (Figure 7a).
HIF1α binds to HRE and activates the transcriptional activity of
target genes. HRE possess two core sequences; 5′‐CACGT‐3′ and
5′‐GCGTG‐3′ (Katoh & Katoh, 2009; Wang & Semenza, 1993). HREs
are located at +104/+108, and +176/+180 region in 5′UTR of ZEB2
gene (Figure 7b). To ascertain the occupancy of HIF1α on the ZEB2
genomic loci, we engineered ZEB2 promoter–luciferase construct
with a mutation in the HREs that abrogate HIF1α binding to ZEB2
promoter and tested the effect of hypoxia on the activity of this
mutant luciferase reporter construct. Site‐directed mutations in
HREs of ZEB2 promoter failed to elicit ZEB2 promoter–reporter
activity in cells exposed to hypoxia (Figure 7b). These results suggest
F IGURE 3 Elevated expression of HIF1α in rat glomerular extracts. Expression of HIF1α and its targets in rat glomerular extracts is shown
as analyzed by immunoblotting (a) and qRT‐PCR (b). Densitometric analysis of western blots (n = 3–4) was normalized to β‐actin expression and
is shown below each blot (a). (b) Error bars indicate mean ± SE; n = 4; *p ≤ 0.05. (c) Immunofluorescence analysis of HIF1α and ZEB2 in the rat
glomeruli. Images were captured at ×63 using a Leica trinocular microscope. HIF1α: hypoxia‐inducible factor‐1α; qRT‐PCR: quantitative
real‐time polymerase chain reaction; TG2: tissue transglutaminase; ZEB2: zinc finger E‐box binding homeobox 2; VEGF: vascular endothelial
growth factor; MMP: matrix metallopeptidase
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that functional HREs present on the ZEB2 promoter are essential for
ZEB2 expression under hypoxic conditions.
To assess the elevated expression of ZEB2 during hypoxia is due
to HIF1α occupancy on the ZEB2 promoter, we next performed ChIP
assay. ChIP assay confirmed that HIF1α occupies ZEB2 promoter in
vivo at the HREs in response to Hypoxia (Figure 7c). The specificity of
these associations was verified by demonstrating a lack of binding to
a region adjacent to HREs in the ZEB2 promoter. We utilized the
interaction of HIF1α with the promoter region of VEGFA, which
serves as a positive control (Forsythe et al., 1996) for the
experimental conditions as VEGFA promoter has HRE (Figure 7c).
As we observed that ZEB2‐NAT was also expressed under hypoxic
condition, we performed promoter analysis of ZEB2‐NAT for the
presence of HREs. We observed HRE sequence (“GCGTG”) at two
regions of ZEB2‐NAT promoter +1145/+1149 and +2945/+2949.
Together, this data suggests that HIF1α elicits ZEB2 protein
accumulation by inducing both ZEB2 mRNA and ZEB2‐NAT expres-
sion wherein ZEB2‐NAT augments the expression of ZEB2 mRNA.
3.7 | ZEB2 knockdown prevents HIF1α‐dependent
decrease in E‐cadherin in podocytes
We next investigated whether ZEB2 plays an essential role in the
HIF1α‐mediated podocyte injury. For this, we utilized podocytes in
which ZEB2 expression was knocked down using shRNA‐mediated
approach. After having confirmed the efficacy and specificity of
knockdown (Figure 7d), these cells were exposed to hypoxia, and the
expression of E‐cadherin was measured by immunoblotting. In
podocytes transduced with lentivirus expressing ZEB2 shRNA,
exposure to hypoxia failed to elicit the decrease in E‐cadherin
expression (Figure 7e). These results suggest that ZEB2 is essential
for transducing the effect of HIF1α on E‐cadherin expression in the
podocytes. Further, we investigated the temporal association of
HIF1α‐induced ZEB2 on E‐cadherin expression using E‐cadherin
promoter construct. E‐cadherin promoter has two E2 boxes
(E2‐box 1: “CAGGTG” & E2‐box 3: “CACCTG”) wherein ZEB2
interacts and transduces the repressive action on E‐cadherin
F IGURE 4 Elevated expression of EMT markers in rat glomerular extracts. qRT‐PCR (a) and immunoblotting (b) showing the expression of
ZEB2, ZEB2‐NAT, and EMT markers. (a) Error bars indicate mean ± SE; n = 4; *p ≤ 0.05. (b) Densitometric analysis of ZEB2 targets normalized for
β‐actin expression is shown below each blot (n = 3–4). (c) Nephroseq (The Regents of The University of Michigan, Ann Arbor, MI) analysis
comparing HIF1A (HIF1alpha), CTNNB1 (beta-catenin), ZEB2, NPHS1 (nephrin), and NPHS2 (podocin) expression levels from patients with CKD
versus control. Expression of HIF1α (2.62‐fold), β‐catenin (1.70‐fold) and ZEB2 (2.7‐fold) are increased; nephrin and podocin expression is
decreased several fold among patients with CKD. CKD: chronic kidney disease; EMT: epithelial–mesenchymal transition; mRNA: messenger
RNA; NAT: natural antisense transcript; qRT‐PCR: quantitative real‐time polymerase chain reaction; ZEB2: zinc finger E‐box binding homeobox
2; ZO-1: zonula occludens-1; FSP-1: fibroblast-specific protein-1
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expression. The specific effect of HIF1α‐induced ZEB2 on E‐cadherin
expression was analyzed using E‐cadherin construct in which ZEB2
binding sites (E2 boxes) were mutated (E‐cad‐E2M). While hypoxia
treatment decreased the activity of E‐cad WT promoter activity, it
had no effect on E‐cad‐E2M (Figure 7f), suggesting that the observed
loss of E‐cadherin expression in hypoxia conditions is due to ZEB2
overexpression.
3.8 | Essential role of ZEB2 in eliciting the effect of
HIF1α on the permeability of podocytes
To assess the functional consequence of hypoxia on podocyte
function, we next examined the podocyte permeability employing
paracellular albumin influx assay. This assay measures the rate of
albumin flux across the podocyte monolayer plated on semiperme-
able PTFE membrane inserts (Figure 8a). After 24 hr of exposure
to hypoxia, albumin was placed in the bottom chamber of
transwell, and the influx of albumin across the podocyte
monolayer was measured at 1 and 4 hr intervals. Increased
albumin influx was noticed across the podocyte monolayer that
was exposed to hypoxia (Figure 8b). These results revealed a
hypoxia‐dependent increase in albumin influx across the podocyte
monolayer. To delineate the role of HIF1α on the permeability of
the podocyte monolayer, we next investigated the effect of HIF1α
in podocytes in which ZEB2 expression was knocked down.
Knocking down of ZEB2 expression resulted in blunting the ability
of hypoxia to elicit an increase in the albumin influx across
podocyte monolayer (Figure 8b). These results suggest that ZEB2
is necessary for transducing the effect of hypoxia on podocyte
permeability. All these data confirm that ZEB2 is the key player in
eliciting the proteinuric effect of elevated HIF1α expression in the
podocytes during hypoxic conditions, wherein hypoxia induces
HIF1α expression, which recognizes and binds to HREs on the
ZEB2 promoter and transactivates its expression. ZEB2, in turn,
regulates the expression of EMT genes, and repression of slit‐
diaphragm components resulting in increased permeability.
F IGURE 5 Hypoxia induces HIF1α, ZEB2 and EMT markers in human podocytes. Immunoblotting (a) and qRT‐PCR (b) analysis of HIF1α,
ZEB2, and its targets in human podocytes in response to hypoxia. (a) Densitometric analysis of protein expression was normalized for β‐actin
expression and is shown below each blot (n = 3–4). (b) The data presented as mean ± SE; n = 4–6; *p < 0.05. (c) Immunofluorescence images
showing elevated expression and colocalization of HIF1α and ZEB2 in podocytes exposed to hypoxia. Images were acquired using ZEISS
confocal microscope. (d) qRT‐PCR analysis of cadherins in HEK293T cells that ectopically express ZEB2; mean ± SE; n = 4–6; *p ≤ 0.05.
HIF1α: hypoxia‐inducible factor‐1α; qRT‐PCR: quantitative real‐time polymerase chain reaction; ZEB2: zinc finger E‐box binding homeobox 2
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4 | DISCUSSION
Prevalence of glomerular dysfunction is prominent in clinical
conditions and adverse environmental conditions wherein hypoxia
prevails. Nevertheless, the pathological events that connect hypoxia
to glomerular dysfunction remain largely unknown. We took up the
current investigation to understand the pathophysiological basis of
the effects of chronic hypoxia on glomerular podocytes. Our study
revealed that in rats exposed to chronic hypoxia, HIF1α is elevated in
glomerular regions. Our results indicate a novel target of HIF1α is the
induction of ZEB2. This increase in ZEB2 expression is due to the
upregulation of ZEB2 mRNA and the induction of NAT of the ZEB2
gene. We demonstrated that HIF1α‐dependent induction of ZEB2 in
the podocytes results in decreased expression of P‐ and E‐cadherin.
P‐cadherin is a component of the podocyte slit‐diaphragm (Reiser,
Kriz, Kretzler, & Mundel, 2000), and E‐cadherin anchors epithelial
junctions and participates in EMT (Batlle et al., 2000). Our studies
also establish that accumulation of HIF1α increases permeability of a
podocyte monolayer, and this effect is a consequence of HIF1α‐
dependent induction of ZEB2. A hyperactive HIF1α–ZEB2 axis is
implicated in the altered podocyte biology, both by initiating EMT
and altered permeability to the slit‐diaphragm (Figure 8c); and our
results provide a molecular basis for the role of hypoxia in the
pathogenesis of glomerular diseases.
The hypoxic condition results in decreased arterial oxygen
pressure that could affect multiple organs including the kidney.
Arterial oxygen pressure is maintained at relatively stable levels by a
unique and complex functional interplay between renal blood flow,
GFR, oxygen consumption, and arteriovenous oxygen shunting
(Haase, 2013; Nangaku, 2011). The fragility of this interplay makes
the kidney vulnerable to hypoxic injury (Haase, 2013). Renal cells
have evolved a variety of molecular mechanisms to adapt to hypoxic
conditions that prevail during development, under extreme physio-
logical and pathological conditions. HIF1α is a predominant tran-
scription factor involved in the control of hypoxia and oxidative
stress responses. It is noteworthy that intrarenal hypoxia is a
proposed pathway to renal dysfunction in conditions such as diabetes
and hypertension (Franzen, Pihl, Khan, Gustafsson, & Palm, 2016).
F IGURE 6 Elevated expression of ZEB2 induces enhanced migration of podocytes. Wound healing assay showing the enhanced migration of
human podocytes (a) and HEK293T cells (b) exposed to hypoxia for varying periods of time. (c) Cell migration is monitored and presented as
percentage of area covered. (d) Western blot analysis of ZEB2 in HEK293T cells overexpressing ZEB2 and quantification of band intensities.
(e) Wound healing assay of HEK293T cells (control and ZEB2 overexpressing) and cell migration is monitored and presented as % area covered.
(c–e) The data are presented as mean ± SE; n = 4–6; *p ≤ 0.05. ZEB2: zinc finger E‐box binding homeobox 2
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Proteinuria is a predominant manifestation of glomerular dysfunc-
tion, and it refers to the alterations particularly in GFB that
otherwise offers permselectivity and prevents loss of protein in the
urine. Therefore, we investigated the effect of hypoxia in renal
cortex, the region where glomeruli are concentrated, and in
podocytes that are instrumental to ensure permselectivity. It is
interesting to note that HIF1α levels have been reported to be
elevated in many organs including the liver, brain, and kidney in
F IGURE 7 Hypoxia induces HIF1α–ZEB2 axis. (a) Luciferase assay in HEK293T cells transiently transfected with indicated constructs and
exposed to hypoxia for 24 hr. Renilla luciferase was used as an internal control to normalize transfection efficiency. (b) Left panel: Schematic
representation of ZEB2 5′UTR showing localization of HREs and point mutations in HREs. Right panel: HEK293T cells were transiently
transfected with ZEB2 promoter–luciferase (ZEB2‐WT) or ZEB2 promoter–luciferase construct with point mutations in the both HREs
(ZEB2‐H2M) and exposed to hypoxia for 24 hr. R. luciferase is used to normalize transfection efficiency. The normalized luciferase activity for
each individual construct exposed to normoxia is designated as 1‐fold. (c) ChIP analysis with chromatin fractions from HEK293T cells exposed
to hypoxia was performed as described. Input DNA and DNA from each of the immunoprecipitated samples were PCR amplified for HRE in both
ZEB2 promoter and VEGFA promoter. (d) Western blot analysis of ZEB2 showing the efficiency of ZEB2 shRNA. (e) Western blot analysis
showing E‐cadherin expression in human podocytes transduced with a lentiviral construct expressing ZEB2 shRNA with and without hypoxia.
(f) Left panel: Schematic representation of E‐cadherin promoter region showing localization of E2‐box 1 and E2‐box 3 and point mutations in
both E2 boxes. Right panel: HEK293T cells were transiently transfected with E‐cadherin promoter–luciferase (E‐cad‐WT) or E‐cadherin
promoter–luciferase construct with point mutations in the both E2‐box 1 and 3 (E‐cad‐E2M) and exposed to hypoxia for 24 hr. R. luciferase is
used to normalize transfection efficiency. The normalized luciferase activity for each individual construct exposed to normoxia is designated as
1 fold. (a–c, e,f) The data are presented as mean ± SE; n = 4–6; *p ≤ 0.05. ChIp: chromatin immunoprecipitation; HIF1α: hypoxia‐inducible
factor‐1α; GHR: growth hormone receptor; HREs: hypoxia response elements; PCR: polymerase chain reaction; shRNA: short hairpin RNA;
ZEB2: zinc finger E‐box binding homeobox 2; VEGFA: vascular endothelial growth factor A
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response to hypoxia and influence target gene expression (Majmun-
dar, Wong, & Simon, 2010). Similarly, in our model HIF1α levels were
significantly upregulated in the kidney compared to liver, and brain.
Our results establish that hypoxia‐induced accumulation of
HIF1α stimulates the expression of ZEB2. ZEB2, also known as
Smad‐interacting protein‐1 (SIP1) and ZFHX1B, belongs to the ZEB
protein family. ZEB2 acts as a transcriptional repressor in both
C‐terminal binding protein (CTBP) dependent and independent
manner (van Grunsven et al., 2003). The expression of ZEB2, a
critical transcriptional factor that orchestrates EMT phenomenon is
regulated by cis‐NAT. We observed expression of ZEB2‐NAT in
podocytes exposed to hypoxia. Since ZEB2 has many potential
targets including crucial proteins of tight junctions, adherence
junctions and gap junctions (Vandewalle et al., 2005), the increase
in ZEB2 could have pleiotropic effects on the podocyte biology
during hypoxia. E‐cadherin is a canonical target for transcriptional
repression by ZEB2. E‐cadherin exists in cytoplasmic vesicles in
podocytes in culture (Reiser et al., 2000). The role of E‐cadherin in
EMT phenomenon is well established, wherein E‐cadherin expression
is downregulated during the transition of cells from epithelial to
mesenchymal phenotype (Palacios, Tushir, Fujita, & D’Souza‐Schorey,
2005). P‐cadherin, another bonafide target of ZEB2, belongs to the
cadherin superfamily and is a component of the slit‐diaphragm
apparatus. Decreased expression of P‐cadherin is implicated in the
pathogenesis of proteinuria and glomerulosclerosis (Boini et al.,
2012; Xu et al., 2005). P‐cadherin mediates cell–cell adhesion
between adjacent podocyte foot processes and also serves as the
basic scaffold for the slit‐diaphragm. It is noteworthy that the key
findings of the current study, HIF1α‐dependent increase in ZEB2 and
the resultant decrease in E‐ and P‐cadherins, were observed in both
F IGURE 8 Activation of HIF1α–ZEB2 axis alters podocyte permselectivity. (a) A simplified schematic representation of the paracellular permeability
assay adopted to assess the filtration barrier function of podocyte monolayer. Podocyte monolayer on collagen‐coated transwell filters was allowed to
differentiate as described in Section 2 and exposed to hypoxia for 24 hr. Albumin was placed in the bottom chamber, and its migration to the upper
chamber was determined at respective intervals. (b) Quantification of albumin influx across podocyte monolayer. Albumin influx is determined at 1 and
4hr following the 24 hr exposure to hypoxia. Podocytes transduced with a lentiviral construct expressing scrambled RNA were considered as a control.
The data are presented as mean± SE; n=4–6; *p<0.05. (c) Proposed model for hypoxia‐mediated podocyte injury. Upon exposure to hypoxia, HIF1α
accumulates, which in turn occupies ZEB2 promoter and drives its expression. ZEB2, in turn, suppresses both P‐ and E‐cadherin to induce EMT.
Decreased E‐cadherin expression is implicated in EMT that results in podocyte dehiscence and loss. These changes in P‐ and E‐cadherin expression will
manifest in effacement of podocyte foot‐processes and proteinuria in pathological states of overactivity of HIF1α–ZEB2 axis in the kidney (CL, capillary
lumen; US, urinary space; G‐glomerular basement membrane; E‐endothelium). EMT: epithelial–mesenchymal transition; HIF1α: hypoxia‐inducible
factor‐1α; shRNA: short hairpin RNA; ZEB2: zinc finger E‐box binding homeobox 2
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HEK cells and human podocytes. In podocytes with a ZEB2
knockdown, HIF1α accumulation fails to provoke the loss of
E‐cadherin; whereas ectopically expressed ZEB2 elicited further loss
of E‐cadherin expression. Furthermore, elevated ZEB2 expression
altered the permselectivity of podocytes to albumin. These results
indicate that ZEB2 is essential for transducing the HIF1α effects on
the permeability of the podocyte monolayer. In addition to ZEB2,
there are other transcription factors that elicit EMT phenomenon
including ZEB1, Snail, and Slug. We observed that basal level ZEB2
expression in podocytes was relatively much higher than compared
with other transcription factors that induce EMT, while ZEB1 protein
expression was only minimally increased during hypoxia (data not
shown).
Besides the loss of E‐ and P‐cadherin expression, several other
proteins are also deregulated during EMT of podocytes including
nephrin and podocin (Nishad et al., 2017). We found attenuated
expression of ZO‐1 and increased expression of N‐cadherin,
β‐catenin, and vimentin in rats exposed to hypoxia. ZO‐1 is a
component of tight junctions, which plays a vital role in regulating
permeability across the epithelium. The decreased expression of
ZO‐1 in podocytes exposed to hypoxia could disrupt the permeability
barrier of the podocytes. The loss of ZO‐1 expression in our study is
concurrent with earlier studies that reported the loss of tight
junction proteins under ischemic conditions (Wagner et al., 2008).
We have also observed the loss of podocyte‐specific proteins nephrin
and podocin in cells exposed to hypoxia. These two proteins are
crucial components of podocyte slit‐diaphragm, and loss of their
expression, particularly nephrin, a major determinant of glomerular
vascular permeability correlates with a loss of glomerular filter
integrity (Hamano et al., 2002). Expression of nephrin and podocin is
also decreased during EMT of podocytes (Li et al., 2008).
The results from this study show that ZEB2 expression is induced
in podocytes under hypoxic conditions. We demonstrate that ZEB2
promoter has HREs and HIF1α interacts with these HRE1 and HRE2
(5′‐GCGTG‐3′ & 5′‐CACGT‐3′). Activation of ZEB2 gene transcrip-
tion is evidenced by an increase in ZEB2 promoter activity under
hypoxic conditions. It is known that the expression of the ZEB2 is
controlled at multiple levels, including transcriptional and posttran-
scriptional. Posttranscriptional regulation of ZEB2 is mediated by
ZEB2‐NAT, wherein ZEB2‐NAT binds to a complementary region on
ZEB2 mRNA. Binding of ZEB2‐NAT with ZEB2 mRNA preserves
internal ribosome entry site of ZEB2 mRNA by preventing splicing of
an intron in ZEB2 mRNA. ZEB2‐NAT mediated control of ZEB2
expression has been described in earlier studies (Beltran et al., 2008;
Katoh & Katoh, 2009). Interestingly, in addition to the ZEB2
expression, we identified the induction of ZEB2‐NAT in hypoxic
conditions. Our study reveals that a two‐level regulation of ZEB2
expression by HIF1α under hypoxic conditions. In addition to our
own observations, meta‐data analysis from Nephroseq also revealed
that elevated expression of HIF1α is associated with ZEB2 over-
expression in CKD. Hence, increased HIF1α and ZEB2 expression is
not only confined to loss of glomerular function under hypoxic
conditions but is also relevant to the pathogenesis of glomerular
dysfunction in CKD.
This report establishes a mechanism for the effect of chronic
hypoxia on glomerular dysfunction. A novel observation of this
study is that hypoxia induces HIF1α, which in turn increases ZEB2
expression in the podocytes, and this action of HIF1α is mediated,
in part, via increased expression of ZEB2‐NAT. The HIF1α‐
dependent increase in ZEB2 ensures both EMT of podocytes and
podocyte foot‐processes effacement. ZEB2 is critical for HIF1α to
exert its deleterious effect on glomerular function in hypoxia via
changes in the epithelial phenotype and permselectivity of
podocytes. We propose that the HIF1α‐dependent increase in
ZEB2 plays a key role in transducing the podocyte injury under
hypoxic conditions and that the HIF1α–ZEB2 axis could be a
molecular basis for podocyte loss and proteinuria during hypoxic
conditions that prevail during several pathological and extreme
physiological conditions.
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